US FDA accepts Bayer’s NDA for elinzanetant to treat moderate-to-severe VMS associated with menopause: Berlin Friday, October 11, 2024, 11:00 Hrs [IST] Bayer announced that the ...

RxDx Assay to identify patients with gastric or GEJ cancer gets CE Mark approval: Basel Friday, October 11, 2024, ...

Pfizer announces positive results from phase 3 TALAPRO-2 trial of Talzenna in combination with Xtandi in patients with mCRPC: New York Friday, October 11, 2024, 09:00 Hrs [IST] Pf ...

Newly launched dementia caregiver training programme by Epoch Elder Care aims to improve care quality: Our Bureau, Mumbai ...

DGFT issues clarification on RCMC requirements for post-export remission-based schemes under FTP 2023: Shardul Nautiyal, Mumbai Friday, October 11, 2024, 08:00 Hrs [IST] The Direc ...

ADMI applauds India's decision to maintain stringent clinical trial requirements for IVDs: Peethaambaran Kunnathoor, Chennai ...

Ankura Hospital announces major expansion plan with focus on enhancing healthcare access: Shardul Nautiyal, Mumbai Friday, October 11, 2024, 08:00 Hrs [IST] The Mumbai-based Ankur ...

High Court refuses interim injunction against Zydus' breast cancer drug: Gireesh Babu, New Delhi Friday, October 11, 2024, 08:00 Hrs [IST] In a setback to Swiss multinational phar ...

The Drugs Controller General of India (DCGI) has communicated to the Karnataka Pharma Retailers & Distributors Organization (KPRDO) that its suggestion to remodel medicine strips is not feasible. In ...

Qinotto, Inc, a central nervous system (CNS) focused biopharmaceutical company discovering novel vehicles to deliver large molecule therapeutics to the brain, announced that it has entered into a ...

ImmuneSensor begins patient dosing in phase 1 trial of lead cGAS inhibitor drug candidate, IMSB301 to treat inflammatory and autoimmune diseases: Dallas, Texas Thursday, October 1 ...

Cellipont Bioservices inks agreement with Mongoose for technology transfer to advance MGB-001 TCR-T cell therapy programme: The Woodlands, Texas Thursday, October 10, 2024, 17:00 ...